LXRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lexicon Pharmaceuticals Inc (LXRX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock shows some positive technical indicators, such as bullish moving averages and a slight pre-market price increase, the lack of significant trading trends, weak financial performance, and absence of strong positive catalysts make it less appealing for long-term investment. The stock's potential for short-term decline (-7.21% in the next month) further supports a cautious approach.
The technical indicators show a mixed picture. The MACD is positive but contracting, suggesting weakening momentum. The RSI is neutral at 65.181, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are at 1.571 and 1.651, with support at 1.311 and 1.231. Pre-market price is up 1.33%, but this is not a strong enough signal for long-term investment.
Bullish moving averages and slight pre-market price increase of 1.33%.
Weak financial performance in Q3 2025, with a significant drop in net income (-80.30% YoY) and EPS (-77.78% YoY). No recent news or significant trading trends. Stock has a 40% chance of declining -7.21% in the next month.
In Q3 2025, revenue increased significantly by 710.40% YoY to $14.18M, but net income dropped to -$12.77M (-80.30% YoY), and EPS fell to -0.04 (-77.78% YoY). Gross margin improved slightly to 99.93% (+4.16% YoY).
No data on recent analyst ratings or price target changes.
